Published on 10 May 2023 on Zacks via Yahoo Finance
ITeos Therapeutics, Inc. (ITOS) Reports Q1 Loss, Misses Revenue Estimates
ITeos Therapeutics, Inc. (ITOS) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to earnings of $1.82 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 55.56%. A quarter ago, it was expected that this company would post earnings of $0.42 per share when it actually produced earnings of $0.57, delivering a surprise of 35.71%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.